UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~October~~January 31, ~~2022~~2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from __________________ to __________________

Commission File Number 0-56333

MYSON, INC.

(Exact Name of registrant as specified in its charter)

Oklahoma		87-1614433
(State or other Jurisdiction of		I.R.S. Employer-
Incorporation or Organization		Identification No.)

7950 W. Sunset Blvd., Ste 629 Los Angeles CA 90046

(Address of Principal Executive Offices and zip code)

(310) 666-0750

(Registrant’s Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Common Stock	MYSN

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13, or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (of for such shorter period that the Registrant was required to file such reports) and (ii) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐		Accelerated filer ☐
Non-accelerated filer ☒		Smaller reporting company ☒
Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date.

As of ~~November~~March 303, ~~2022~~2023, there were 10,133,284 shares of Common Stock, $.00001 par value.

MYSON, INC.

FORM 10-Q

For the Period ended ~~October~~January 31, ~~2022~~2023

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION 3 Item 1. Financial Statements 3 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 10 Item 3. Quantitative and Qualitative Disclosures About Market Risk 12 Item 4. Controls and Procedures 12 PART II – OTHER INFORMATION 13 Item 1. Legal Proceedings 13 Item 1A. Risk Factors 13 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 13 Item 3. Defaults Upon Senior Securities 13 Item 4. Mine Safety Disclosures 13 Item 5. Other Information 13 Item 6. Exhibits 1314 SIGNATURES 1415

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Condensed Balance Sheets as of October 31, 2022 (unaudited) and July 31, 2022 (audited)	4
Condensed Balance Sheets as of January 31, 2023 (unaudited) and July 31, 2022 (audited)	4
Condensed Statements of Operations for the Three Months ended October 31, 2022 and 2021 (unaudited)	5
Condensed Statements of Operations for the Three and Six Months ended January 31, 2023 and 2022 (unaudited)	5
Condensed Statement of Changes in Stockholders’ Deficit for the Three Months ended October 31, 2022 and 2021 (unaudited)	6
Condensed Statement of Changes in Stockholders’ Deficit for the Three and Six Months ended January 31, 2023 and 2022 (unaudited)	6
Condensed Statements of Cash Flows for the Three Months ended October 31, 2022 and 2021 (unaudited)	7
Condensed Statements of Cash Flows for the Six Months ended January 31, 2023 and 2022 (unaudited)	7
Notes to Condensed Financial Statements (unaudited)	8

MYSON, INC.

CONDENSED BALANCE SHEETS

	October 31, 2022			July 31, 2022
	January 31, 2023			July 31, 2022
	(Unaudited)			(Audited)
ASSETS
Current Assets:
Cash	$	—		$	—
Total Current Assets		—			—
Total Assets	$	—		$	—
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable	$	~~16,036~~350		$	282
Loan payable – related party		4675,~~699~~047			37,649
Total Current Liabilities		6275,~~735~~397			37,931
Stockholders’ Deficit:
Preferred stock, $0.00001 par value, 20,000,000 shares authorized		—			—
Series A Preferred stock, $0.00001 par value, 1,000,000 shares designated, 1,000 shares issued and outstanding		—			—
Preferred stock, value		—-			—-
Common stock, $0.00001 par value, 480,000,000 shares authorized; 10,133,284 shares issued and outstanding		101			101
Additional paid in capital		27,639			27,639
Accumulated deficit		(90103,~~475~~137	)		(65,671	)
Total stockholders’ deficit		(6275,~~735~~397	)		(37,931	)
Total Liabilities and Stockholders’ Deficit	$	—		$	—

The accompanying notes are an integral part of these unaudited condensed financial statements.

MYSON, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	2022			2021
	2023			2022			2023			2022
	For the Three Months Ended October 31,
	For the Three Months Ended January 31,						For the Six Months Ended January 31,
	2022			2021
	2023			2022			2023			2022
Operating expenses:
General and administrative	$	2412,~~804~~662		$	204,~~152~~551		$	37,466		$	24,703
Total operating expenses		2412,~~804~~662			204,~~152~~551			37,466			24,703
Loss from operations		(2412,~~804~~662	)		(204,~~152~~551	)		(37,466	)		(24,703	)
Net Loss	$	(2412,~~804~~662	)	$	(204,~~152~~551	)	$	(37,466	)	$	(24,703	)
Loss per share, basic & diluted	$	(0.00	)	$	(0.1500	)	$	(0.00	)	$	(0.00	)
Weighted average shares outstanding, basic & diluted		10,133,284			10,133,284			10,133,284			10,133,284

The accompanying notes are an integral part of these unaudited condensed financial statements.

MYSON, INC.

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED ~~OCTOBER~~JANUARY 31, ~~2022~~2023 AND ~~2021~~2022

(Unaudited)

	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
	Common Stock				Series A Preferred Stock				Additional Paid in		Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balances, July 31, 2021		133,284	$	1		1,000	$	—	$	100	$	(101	)	$	—
Contributions to capital		—		—		—		—		19,520		—			19,520
Net loss		—		—		—		—		—		(20,152	)		(20,152	)
Balances, October 31, 2021		133,284	$	1		1,000	$	—	$	19,620	$	(20,253	)	$	(632	)
Contributions to capital		—		—		—		—		4,901		—			4,901
Net loss		—		—		—		—		—		(4,551	)		(4,551	)
Balances, January 31, 2022		133,284	$	1		1,000	$	—	$	24,520	$	(24,804	)	$	(282	)

	Common Stock				Series A Preferred Stock				Additional Paid in		Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balances, July 31, 2022		10,133,284	$	101		—	$	—	$	27,639	$	(65,671	)	$	(37,931	)
Net loss		—		—		—		—		—		(24,804	)		(24,804	)
Balances, October 31, 2022		10,133,284	$	101		—	$	—	$	27,639	$	(90,475	)	$	(62,735	)
Beginning balance, value		10,133,284		101		—		—		27,639		(90,475	)		(62,735	)
Net loss		—		—		—		—		—		(12,662	)		(12,662	)
Balances, January 31, 2023		10,133,284	$	101		—	$	—	$	27,639	$	(103,137	)	$	(75,397	)
Ending balance, value		10,133,284	$	101		—	$	—	$	27,639	$	(103,137	)	$	(75,397	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

MYSON, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	2022			2021
	2023			2022
	For the Three Months Ended October 31,
	For the Six Months Ended January 31,
	2022			2021
	2023			2022
Cash Flows from Operating Activities:
Net loss	$	(2437,~~804~~466	)	$	(2024,~~152~~703	)
Adjustments to reconcile net loss to net cash used in Operating activities:
Changes in Operating Assets and Liabilities:
Accounts payable		~~15,754~~68			~~632~~282
Net cash used by operating activities		(937,~~050~~398	)		(1924,~~520~~421	)
Cash Flows from Financing Activities:
Loan payable – related party
Contributions to capital by controlling shareholder		937,~~050~~398			1924,~~520~~421
Net cash provided by financing activities		937,~~050~~398			1924,~~520~~421
Net change in cash		—			—
Cash, at beginning of period		—			—
Cash, at end of period	$	—		$	—
Supplemental Non-Cash Disclosure:
Cash paid for interest	$	—		$	—
Cash paid for taxes	$	—		$	—

The accompanying notes are an integral part of these unaudited condensed financial statements.

MYSON, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

~~October~~January 31, ~~2022~~2023

NOTE 1 – NATURE OF OPERATIONS

Myson, Inc. (“Myson”, or the “Company”) is an Oklahoma corporation formed on July 8, 2021. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of ~~July~~January 31, ~~2022~~2023, the Company has not commenced any operations. All activity for the period from July 8, 2021 (inception) through ~~July~~ January 31, ~~2022~~2023, relates to the Company’s formation and the filing of its Registration Statement on Form 10, which was effective on October 23, 2021, and the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest.

On May 11, 2022, G. Reed Petersen Irrevocable Trust (the “Seller”), agreed to sell all 1,000 issued and outstanding Series A Preferred Shares of the Company to Reddington Partners LLC (the “Purchaser”), thus constituting a change of control of the Company, for $495,000, pursuant to a Stock Purchase Agreement (the “Stock Purchase Agreement”). The Preferred Shares were convertible into 10,000,000 common shares which, upon conversion, represent approximately 98.7% of the Company’s outstanding common shares. On June 8, 2022, Reddington Partners LLC converted their Series A Preferred Shares into 10,000,000 common shares, and there are no Preferred Shares currently issued and outstanding.

The sale of the Shares to the Purchaser was completed on May 17, 2022. As part of the Stock Purchase Agreement, G. Reed Petersen agreed to resign as the Company’s sole officer and director; and the change of management was completed on June 5, 2022. On June 6, 2022, Henrik Rouf became the Company’s sole officer and director.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The Company’s unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending July 31, 2023. These unaudited condensed financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2022.

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

Cash and Cash Equivalents

The Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less as cash and cash equivalents. The carrying amount of financial instruments included in cash and cash equivalents approximates fair value because of the short maturities for the instruments held. The Company had no cash equivalents as of ~~October~~January 31, ~~2022~~2023 and July 31, 2022.

Basic and Diluted Earnings Per Share

Net income (loss) per common share is computed pursuant to ASC 260-10-45, Earnings per Share—Overall—Other Presentation Matters. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The Company has no potentially dilutive shares of common stock as of ~~October~~January 31, ~~2022~~2023 and July 31, 2022.

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 3 – GOING CONCERN

These unaudited financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At ~~October~~January 31, ~~2022~~2023, the Company has not yet achieved profitable operations, has accumulated losses of $90103,~~475~~137 since its inception, has no working capital, and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however, there is no assurance of additional funding being available or on terms acceptable to the Company.

NOTE 4 - RELATED PARTY TRANSACTIONS

During the ~~three~~six months ended ~~October~~January 31, ~~2022~~2023, Reddington Partners LLC, the majority shareholder, advanced the Company $937,~~050~~398 to pay for general operating expenses. As of ~~October~~January 31, ~~2022~~2023, the Company owes Reddington Partners LLC, a total of $4675,~~699~~046 for advances to the Company. The advances are non-interest bearing and due on demand.

NOTE 5 – COMMON STOCK

The Company has authorized 480,000,000 shares of common stock, par value $0.00001.

Effective February 24, 2022, the Company effectuated a 1 for 10,000 reverse stock split. All share numbers throughout these financial statements have been retroactively restated.

NOTE 6 – PREFERRED STOCK

The Company has authorized 20,000,000 shares of preferred stock, par value $0.00001. The Preferred Stock authorized by these Articles of Incorporation may be issued in one or more series. The Board of Directors of the Corporation is authorized to determine or alter the rights, preferences, privileges, and restrictions granted or imposed upon any wholly unissued series of Preferred Stock, and within the limitations or restrictions stated in any resolution or resolutions of the Board of Directors originally fixing the number of shares constituting any series, to increase or decrease (but not below the number of shares of any such series then outstanding) the number of shares of any such series subsequent to the issue of shares of that series, to determine the designation and par value of any series and to fix the numbers of shares of any series.

Of the authorized preferred stock 1,000 shares have been designated as Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is convertible into 10,000 shares of common stock and has 100,000 voting rights per share.

On June 8, 2022, the Reddington Partners LLC converted the Series A Preferred Shares into 10,000,000 common shares.

NOTE 7 - SUBSEQUENT EVENTS

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were issued and has determined that no material subsequent events exist.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

General Overview

We were incorporated on July 8, 2021 as an Oklahoma corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We intend to effectuate our initial business combination using our capital stock, debt or a combination of cash, stock and debt.

Current Business

We have neither engaged in any operations nor generated any operating revenues to date. We are currently a “shell,” as that term is defined pursuant to Rule 12b-2 of the Securities Exchange Act of 1934. Our only activities for the period from July 8, 2021 (inception) through ~~October~~January 31, ~~2022~~2023 were organizational activities, preparing and filing a Form 10 with the SEC, and then identifying a target company for a business combination. We will not generate any operating revenues until after completion of our initial business combination. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

Results of Operations

Results of Operations for the Three Months Ended ~~October~~January 31, ~~2022~~2023 ~~and~~Compared ~~2021~~to the Three Months Ended January 31, 2022

Revenue

We did not recognize any revenue for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022.

General and administrative

General and administrative expense was $2412,~~804~~662 and $204,~~152~~551 for the three months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022, respectively. Expenses were ~~for~~ for accounting fees, transfer agent fees, edgarization fees and postage expenses, primarily related to the costs of maintaining our company current with the transfer agent and with our filing obligations with the Securities and Exchange Commission.

Net Loss

For the three months ended ~~October~~January 31, ~~2022~~2023, we had a net loss of $2412,~~804~~662 as compared to a net loss of $204,~~152~~551 for the three months ended ~~October~~January 31, ~~2021~~2022.

Results of Operations for the Six Months Ended January 31, 2023 Compared to the Six Months Ended January 31, 2022

Revenue

We did not recognize any revenue for the six months ended January 31, 2023 and 2022.

General and administrative

General and administrative expense was $37,466 and $24,703 for the six months ended January 31, 2023 and 2022, respectively. Expenses were for accounting fees, transfer agent fees, edgarization fees and postage expenses, primarily related to the costs of maintaining our company current with the transfer agent and with our filing obligations with the Securities and Exchange Commission.

Net Loss

For the six months ended January 31, 2023, we had a net loss of $37,466 as compared to a net loss of $24,703 for the six months ended January 31, 2022.

Liquidity and capital resources.

The Company has no working capital, with all of its foreseeable capital needs being met by contributions or loans from its sole officer and director. The Company has no business at this time and is seeking to acquire another business.

Cash flows

Operating Activities

Cash used by operating activities was $937,~~050~~398 for the ~~three~~six months ended ~~October~~January 31, ~~2022~~2023, compared to cash used for operating activities of $1924,~~250~~421 for the ~~three~~six months ended ~~October~~January 31, ~~2021~~2023.

Investing Activities

We used $0 for investing activities for the ~~three~~six months ended ~~October~~January 31, ~~2022~~2023 and ~~2021~~2022.

Financing Activities

Net cash provided by financing activities was $937,~~050~~398 for ~~three~~six months ended ~~October~~January 31, ~~2022~~2023, compared to $1924,~~520~~421 for the ~~three~~six months ended ~~October~~January 31, ~~2021~~2022. During the current period we received $937,~~050~~398 from the majority shareholder. During the prior period, we received $1924,~~250~~421 that was contributed by the former majority shareholder.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Critical Accounting Policies

Refer to Note 2 of our financial statements contained elsewhere in this Form 10-Q for a summary of our critical accounting policies and recently adopting and issued accounting standards.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

We conducted an evaluation of the effectiveness of our internal control over financial reporting, based on the framework in “Internal Control Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and published in 2013, and subsequent guidance prepared by COSO specifically for smaller public companies. Based on that evaluation, management concluded that our internal control over financial reporting was not sufficient as of ~~October~~January 31, ~~2022~~2023.

A significant deficiency is a deficiency, or combination of deficiencies in internal control over financial reporting, that adversely affects the entity’s ability to initiate, authorize, record, process, or report financial data reliably in accordance with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of the entity’s financial statements that is more than inconsequential will not be prevented or detected by the entity’s internal control. A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. Management identified the following material weakness and significant deficiencies in its assessment of the effectiveness of internal control over financial reporting as of ~~October~~January 31, ~~2022~~2023:

	●	The Company did not maintain effective controls over certain aspects of the financial reporting process because we lacked personnel with accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements.

	●	Material Weakness – Inadequate segregation of duties.

We expect to be materially dependent on a third party that can provide us with accounting consulting services for the foreseeable future. Until such time as we have a chief financial officer with the requisite expertise in U.S. GAAP, there are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements. Our management does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and maintained, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must account for resource constraints. In addition, the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, can and will be detected.

This Quarterly Report on Form 10-Q does not include an attestation report from our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Commission that permit us to provide only management’s report in this Quarterly Report on Form 10-Q.

Changes in Internal Controls over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.

Item 1A. Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceed

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

Item 6. Exhibits

Exhibit No.	Description	Note
2.1	Agreement and Plan of Merger dated July 8, 2021	(1)
3.(i)1	Articles of Incorporation	(1)
3.(i)2	Bylaws	(1)
31	Certification of Chief Executive and Financial Officer (Rule 13a-14(a))	Filed herewith
32	Certification of Chief Executive and Financial Officer (18 USC 1350)	Filed herewith
101 INS	Inline XBRL Instance Document	Filed herewith
101 SCH	Inline XBRL Taxonomy Extension Schema Document.	Filed herewith
101 Cal	Inline XBRL Taxonomy Extension Calculation Linkbase Document.	Filed herewith
101 DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.	Filed herewith
101 LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.	Filed herewith
101 PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.	Filed herewith
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).	Filed herewith

(1) Incorporated by reference to such exhibit as filed with the Company’s Registration Statement on Form 10 filed on August 23, 2021.

1314

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

MYSON, INC.
Date: December 6, 2022
Date: March 13, 2023
By	/s/ Henrik Rouf
	Henrik Rouf
	Chief Executive Officer and Chief Financial Officer

1415

Filing Compare · Mag Mile Capital, Inc.